RedHill Biopharma Mourns the Passing of Dr. Joshua Schein

1 July, 2019

It is with profound sadness that we announce the passing of Dr. Joshua Schein, PhD, a member of RedHill Biopharma’s Advisory Board.

“We are deeply saddened by the passing of our colleague, dear friend and Advisory Board member, Dr. Joshua Schein,” said Dror Ben-Asher, RedHill’s Chief Executive Officer. “We were very fortunate to have Josh as an early and long-time supporter of RedHill and a key member of our Advisory Board. We will miss him dearly and will be forever grateful for his wisdom and invaluable guidance. With the rest of the RedHill team, I offer our deepest condolences and sympathies to his family and friends during this difficult time.”